Skip to main content
. Author manuscript; available in PMC: 2021 Feb 1.
Published in final edited form as: J Cell Biochem. 2019 Oct 8;121(2):1736–1746. doi: 10.1002/jcb.29409

Table 5.

mRNA ISH staining among DCIS Patients (N=74 – 84)

Probe Positive Negative
Proliferation§ Gp. 20 (24.1%) 63 (75.9%)
Non-Proliferation Gp. 20 (24.5%) 62 (75.6%)
Prolif.1 or Non-Prolif. Gp. 29 (35.4%) 53 (64.6%)
Prolif. & Non-Prolif.§, Gps. 11 (14.9%) 63 (85.1%)
MKI67 5 (6.1%) 77 (93.9%)
TGFB1 5 (20.0%) 75 (80.0%)
TLR2 0 83 (100%)
GLTSCR2 47 (60.3%) 31 (39.7%)
GLO1 33 (42.9%) 44 (57.1%)

N values vary due to TMA tissue spot drop-out ‘missing data points’;

≥10% staining.

§

(BIRC5, Cyclin B1, MKI67, MYBL2, STK15);

(CEACAM5, HTF9C, NDRG1, SLC7A5, TP53)